PLUMB PHARMACEUTICALS, INC
Biotech · Private
Extended-release naltrexone formulation using proprietary Advanced Quantload technology for opioid addiction maintenance therapy
- Grants
- $503K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 1 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Refining a 3-month release buprenorphine, advancing a drug delivery platform | $224,850 | |
| Federal grant | Department of Health and Human Services · Phase I · A 3-month Release Naltrexone for Addiction Treatment | $202,563 | |
| Federal grant | Department of Health and Human Services · Phase I · A 3-month Release Naltrexone for Addiction Treatment | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A 3-month Release Naltrexone for Addiction Treatment | $20,186 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2949 | Vitanova Biomedical, Inc. | — | $8.0M |
| 2950 | OnCusp Therapeutics | — | — |
| 2951 | COVALABIO INC. | — | — |
| 2952 | PLUMB PHARMACEUTICALS, INC | — | — |
| 2953 | Stem Cell Development Fund, LLC | — | $2.8M |
| 2954 | TISSUEFORM, INC. | — | — |
| 2955 | Diasome Pharmaceuticals, Inc. | — | $50M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Liposome Loadingapplication
- Liposome Loadinggranted
- Liposome Loading With Polyanionsapplication
- Liposome Loading With Polyanionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.